GSE153354 TCF19 knockout CAL-27 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE153354_TCF19 knockout_CAL-27_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE153354_TCF19 knockout_CAL-27_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE153354_TCF19 knockout_CAL-27_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE153354_TCF19 knockout_CAL-27_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

small nucleolar RNA host gene 3

Gene

Pvt1 oncogene

Gene

oligodendrocyte maturation-associated long intergenic non-coding RNA

Gene

HOXA transcript antisense RNA, myeloid-specific 1

Gene

NSUN5 pseudogene 1

Gene

long intergenic non-protein coding RNA 1963

Gene

NmrA like redox sensor 2, pseudogene

Gene

uncharacterized LOC339260

Gene

transmembrane protein 198B (pseudogene)


  • Gene

    small nucleolar RNA host gene 3



  • Gene

    oligodendrocyte maturation-associated long intergenic non-coding RNA


  • Gene

    HOXA transcript antisense RNA, myeloid-specific 1


  • Gene

    NSUN5 pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    uncharacterized LOC339260


  • Gene

    transmembrane protein 198B (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.